[28-20-am] Pathophysiology (Oncology) | The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-20-am]Pathophysiology (Oncology)

Fri. Mar 28, 2025 8:30 AM - 9:54 AM JST
Fri. Mar 28, 2025 11:30 PM - 12:54 AM UTC

Room 20 (FUKUOKA SUNPALACE: Palace RoomB [2F])

Chair: Yoichi Ishitsuka, Kazuhiro Yamamoto

8:30 AM - 8:42 AM JST(11:30 PM - 11:42 PM UTC)

[28-20-am01]Impact of surgical procedure on prognosis in lung cancer: a real-world data analysis

○Toshihiko Yoshioka^1,2, Kenta Yagi^1,3, Taihei Takeuchi⁴, Takahiro Niimura^1,3, Fuka Aizawa^1,2, Mitsuhiro Goda^1,2, Kei Kawada^1,5, Yuki Izawa -Ishizawa^1,6, Hiromitsu Takizawa⁴, Keisuke Ishizawa^1,2,3 (1. Clin. Pharm., Grad. Sch. Biomed. Sci., Tokushima Univ., 2. Dept. Pharm., Tokushima Univ. Hosp., 3. Clin. Res. Ctr. Dev. Therap., Tokushima Univ. Hosp., 4. Analyt. Pathol., Grad. Sch. Biomed. Sci., Tokushima Univ., 5. Clin. Pharm. Pract. Pedagogy., Grad. Sch. Biomed. Sci., Tokushima Univ., 6. Dept. Gene. Med., Taoka. Hosp.)

8:42 AM - 8:54 AM JST(11:42 PM - 11:54 PM UTC)

[28-20-am02S]The underlying mechanism for promotion of the glioblastoma malignancy by Jumonji and AT-Rich Interaction Domain containing 2

○Takuto Inoki¹, Akito Tsuruta¹, Yuichiro Kai¹, Yuya Yoshida¹, Naoya Matsunaga¹, Shigehiro Ohdo¹, Satoru Koyanagi¹ (1. Fac. Sch. Pharm. Sci., Kyushu Univ.)

8:54 AM - 9:06 AM JST(11:54 PM - 12:06 AM UTC)

[28-20-am03S]Analysis of the circadian regulation mechanism of glutamine metabolism in murine liver cancer cells

○Daishu Terada¹, Tomoaki Yamauchi¹, Akito Tsuruta¹, Satoru Koyanagi¹ (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)

9:06 AM - 9:18 AM JST(12:06 AM - 12:18 AM UTC)

[28-20-am04]Evaluation of efficacy and hematologic toxicity of BRD4/CBP/p300 combined inhibition for pediatric MLL-rearranged acute lymphoblastic leukemia

○Natsuki Imayoshi^1,2, Kyona Yamamoto^1,3, Mio Shimada^1,3, Masahiro Tsuda^1,3, Tomohiro Terada¹, Eishi Ashihara² (1. Dept. Clin. Pharmacol. Ther., Kyoto Univ. Hosp., 2. Lab. of Clin. Transl. Physiol., Kyoto Pharmaceutical Univ., 3. Grad. Sch. Pharm. Sci., Kyoto Univ.)

9:18 AM - 9:30 AM JST(12:18 AM - 12:30 AM UTC)

[28-20-am05S]Inhibition of PF4 by neutralizing antibodies suppresses intratumor Th1-type Treg differentiation and activates antitumor immunity

○Ayumi Kuratani¹, Masahiro Yamamoto^1,2,3,4 (1. RIMD, Osaka Univ., 2. iFRec, Osaka Univ., 3. CiDER, Osaka Univ., 4. CAMaD, Osaka Univ.)

9:30 AM - 9:42 AM JST(12:30 AM - 12:42 AM UTC)

[28-20-am06S]Monocarboxylate transporter 7 contributes to anti-cancer drug resistance in breast cancer cells

○Misato Kunieda¹, Kei Higuchi^1,2, Yuito Otsuka², Himari Minato², Hisanao Kishimoto^1,2, Katsuhisa Inoue^1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Pharm., 2. Sch. Pharm. Sci., Tokyo Univ. Pharm.)

9:42 AM - 9:54 AM JST(12:42 AM - 12:54 AM UTC)

[28-20-am07S]TNFR2 on Monocytic-MDSC is required for suppressive activity

○Yuta Tsuji¹, Masaki Inoue², Shin-ichi Tsunoda^1,2 (1. Grad. Sch. Pharm. Sci., Kobe Gakuin Univ., 2. Fac. Pharm. Sci., Kobe Gakuin Univ)

Back to Category List